Domol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Domol

What is Domol?

Domol is a pharmacological agent primarily used to manage symptoms associated with gastrointestinal motility disorders. It belongs to a class of medications known as dopamine antagonists. By interacting with specific receptors in the digestive tract and the brain's chemoreceptor trigger zone, it facilitates the movement of food through the stomach and intestines.

Mechanism of Action

The active component in Domol works by blocking dopamine receptors. In the gastrointestinal tract, this action increases the tone of the lower esophageal sphincter and enhances the coordination of gastroduodenal contractions. This process accelerates gastric emptying, which helps alleviate sensations of fullness and bloating.

Additionally, its effect on the central nervous system is limited because it does not easily cross the blood-brain barrier. However, it does reach the area of the brain responsible for inducing the vomiting reflex, which contributes to its ability to suppress nausea.

Common Uses

Domol is typically utilized for the following indications:

  • Dyspepsia: Relief from discomfort caused by delayed gastric emptying, such as upper abdominal bloating or a feeling of excessive fullness after meals.
  • Nausea and Vomiting: Management of symptoms arising from various causes, including those related to other medications or digestive disturbances.
  • Gastroesophageal Reflux: Support in treating the symptoms of acid reflux by encouraging the downward movement of stomach contents.

Composition and Forms

Domol is most frequently available in tablet form for oral administration. The formulation is designed to release the active ingredient in a manner that allows for effective absorption within the digestive system. While the concentration may vary depending on the specific product line, the core therapeutic goal remains the stabilization of gut motility.

What side effects are possible with Domol?

Possible Side Effects and Safety Information

The official safety profile for Domol (Rabeprazole), a Proton Pump Inhibitor, is established through clinical trials and post-marketing surveillance, as documented by governmental regulatory authorities. Adverse reactions are formally classified by incidence and the physiological system affected.

Frequency-Classified Adverse Reactions

Adverse events are categorized by frequency. Common reactions (occurring in ge 1/100 to <1/10 patients) typically include headache, diarrhea, nausea, abdominal pain, vomiting, flatulence, and infection. Uncommon reactions (ge 1/1,000 to <1/100) include nervousness, somnolence, bronchitis, joint pain (arthralgia), and peripheral edema (swelling of extremities).

Serious Adverse Reactions and Safety Constraints

Official labeling describes several serious events and specific constraints:

  • Serious Risks: These include an increased risk of bone fracture (hip, wrist, spine) and hypomagnesemia (low magnesium levels), particularly associated with prolonged use (typically one year or longer). Rare reactions such as Acute Tubulointerstitial Nephritis (TIN) and an association with Clostridium difficile-Associated Diarrhea (CDAD) are also documented.
  • Duration-Related Patterns: Use longer than three years may be associated with Vitamin B12 deficiency due to reduced acid absorption. Withdrawal after prolonged use may result in rebound acid hypersecretion.
  • Safety Constraints: The label specifies that symptomatic response to Domol does not preclude the presence of gastric malignancy, which must be excluded prior to treatment. Caution is officially advised for patients with severe hepatic impairment.

This framework ensures that potential risks are organized by incidence and exposure duration, providing a comprehensive, non-advisory description of the medicine’s official safety characteristics.

Overdose and Emergency Response

Domol Overdose and When to Seek Help

An overdose of Domol, which contains the active ingredient acetaminophen (paracetamol), can be extremely serious and may lead to severe liver damage or failure. It is critical to recognize that symptoms of overdose are often mild or non-existent in the first 24 hours, which can create a false sense of security. Prompt medical attention is vital, even if the person feels well.

Symptoms of Overdose

Initial signs, usually within the first day, can be non-specific and may include:

  • Nausea and Vomiting
  • Loss of Appetite
  • Abdominal Pain
  • Sweating and Pallor

As toxicity progresses (typically after 24 to 72 hours), signs of liver damage may appear, such as pain in the upper right abdomen, confusion, and jaundice (yellowing of the skin and eyes). Kidney failure and other complications can also occur.

When to Seek Immediate Help

Call your local emergency number immediately if you suspect that you or someone else has taken more than the recommended dose of Domol. This applies even if no symptoms are present. It is important to know the time of ingestion and the amount taken, if possible.

Immediate treatment, often with the antidote N-acetylcysteine, is most effective when administered within eight hours of an acute overdose and can significantly reduce the risk of serious liver injury.

Therapeutic Uses of Domol

Domol (Rabeprazole) is commonly used to help with symptoms related to heightened physiological activity across multiple therapeutic domains. It addresses symptom clusters that may become intense or disruptive, assisting with maintaining functional stability during difficult episodes.

Therapeutic Uses and Symptom Domains

Domol is relevant in conditions presenting with systemic or localized discomfort and is commonly used for erosive esophagitis, symptomatic GERD, the management of duodenal ulcers, and complex conditions like Zollinger-Ellison Syndrome. It is applied in clinical settings that involve acute or unstable symptom patterns, where short-term symptomatic assistance is needed to address symptoms linked to heightened physiological activity. This generally provides support that helps ease the overall symptom burden.

Relief for Disruptive Manifestations

This medication helps address symptom clusters such as severe heartburn and acid regurgitation that may become intense or disruptive. It is commonly used when short-term symptomatic assistance is needed in conditions marked by heightened symptoms. It supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load during periods of acute or recurrent manifestations. Domol is also applied as a key component in H. pylori eradication to help manage associated ulcer symptoms.

Quick Fact: Use in Symptomatic Heartburn
The medication is considered relevant for easing symptoms that are frequent, persistent, and interfere with daily comfort.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Domol?

Eligibility for Domol (rabeprazole sodium) is strictly governed by regulatory classifications, defining populations who are approved for use and those who are formally contraindicated.


Absolute Non-Eligibility (Contraindications)

Domol is contraindicated and must not be used in patients with a known hypersensitivity to rabeprazole, any component of the formulation, or any drug belonging to the substituted benzimidazole class. Use is also prohibited for patients receiving rilpivirine-containing products.

Age and Organ Function Eligibility

  • Adults and Adolescents: The medicine is approved for use in adults for all labeled indications. Use is established for adolescents 12 years and older for symptomatic GERD. Children 1 to 11 years of age are eligible only for GERD treatment; efficacy for adult indications is not established.
  • Infants: Use is not recommended in infants younger than one year of age because clinical studies failed to demonstrate efficacy.
  • Organ Function: No dosage adjustment is necessary for patients with renal impairment or mild to moderate hepatic impairment. Caution must be exercised when initiating treatment in patients with severe hepatic dysfunction.

Physiological Restrictions

Use is contraindicated during both pregnancy and breastfeeding/lactation according to some international regulatory guidelines.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions involving Domol, which typically contains a prokinetic agent (Domperidone) and an acid-suppressing agent (like Rabeprazole), are formally documented based on two primary mechanisms: effects on cardiac risk and alterations in the gastrointestinal environment.

Contraindicated and High-Risk Combinations

Strict regulatory contraindications exist against combining Domol with specific medicine classes. This includes strong CYP3A4 inhibitors (such as certain macrolide antibiotics like Erythromycin or azole antifungals like Ketoconazole) as these increase Domperidone plasma concentrations, heightening the risk of serious cardiac events.

Co-administration with other medicines known to prolong the QTc interval is also prohibited due to an additive cardiac risk.

Pharmacokinetic and Absorption Interactions

The acid-suppressing component alters gastric pH, significantly impacting the absorption of many other medications. Medicines whose absorption is decreased include Ketoconazole and Itraconazole, while the absorption of drugs like Digoxin may be increased.

Specific antiretroviral drugs, such as Atazanavir, may experience severely reduced plasma concentrations when co-administered with the acid suppressor, potentially leading to loss of therapeutic effect.

Population and Timing Notes

Official labeling indicates that elderly patients and those with moderate or severe hepatic impairment carry a higher risk of interaction-related complications due to altered drug metabolism.

Mechanism of Action

How Domol Works

Domol operates through a dual-mechanism pharmacodynamic action, modulating two independent yet physiologically linked systems in the upper digestive tract.

Inhibition of Gastric Acid Production

One component targets the Hydrogen-Potassium Adenosine Triphosphatase (H^+/K^+-ATPase) enzyme, commonly known as the Proton Pump, which is situated on the surface of parietal cells in the stomach lining. The drug forms an irreversible, covalent bond with the pump, thereby blocking the final molecular step of acid secretion. This interaction results in the sustained inhibition of acid secretion within the stomach.

Modulation of Upper Digestive Motility

The second component functions as an antagonist at dopamine D2 receptors primarily located in the upper gastrointestinal (GI) tract. Antagonism of these peripheral D2 receptors counteracts dopamine's inhibitory signaling on smooth muscle contraction. This mechanistic cascade facilitates the release of acetylcholine, a neurotransmitter that enhances gastric contractility and coordinates the propulsion of contents through the stomach, regulating GI movement.

Dosage and Administration Information

How Domol (Rabeprazole Sodium) Is Used

Domol (rabeprazole sodium) is administered exclusively by the oral route, primarily available as a delayed-release tablet or capsule. This medicine is intended for standardized consumption based on established guidelines concerning dose, frequency, and administration context.

Official Administration Guidelines

Feature Guideline
Administration Method The delayed-release tablet must be swallowed whole. It is restricted to crush, chew, or split the tablet to ensure the protective enteric coating remains intact.
Dosing Frequency Typically Once Daily for most standard conditions, such as healing erosive esophagitis. Specific regimens, including the use for H. pylori eradication, require Twice Daily dosing.
Dosing Schedules (Adults) Standard Dose: 20 mg once daily. High-Dose Regimen: 60 mg up to 100 mg once daily, or 60 mg twice daily, for pathological hypersecretory conditions.
Timing Relative to Food Generally taken with or without food. However, specific regimens, such as for duodenal ulcer healing, advise taking the dose after the morning meal.
Acute Duration Treatment for acute conditions, such as healing ulcers or erosive esophagitis, typically spans four to eight weeks.

Use in Specific Populations

Standard protocols indicate that no dose adjustment is specified for patients with renal impairment or mild to moderate hepatic impairment. For pediatric patients (ages one to eleven), recognized regimens utilize 5 mg or 10 mg once daily, often via the sprinkle capsule formulation. If a dose is missed, instructions specify to take it as soon as it is remembered, unless it is nearly time for the next dose; doubling the dose is prohibited.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Domol (Rabeprazole)

The following summary outlines the types of clinical research that have explored Domol (Rabeprazole), focusing on the design of the studies, the outcomes measured, and where evidence may be limited, while strictly avoiding clinical advice or safety information.


Evidence for Healing and Maintenance of Healed Erosive Esophagitis

Domol was studied for the short-term healing of the damaged esophageal lining in individuals diagnosed with erosive or ulcerative esophagitis. The research included short-term Randomized Controlled Trials (RCTs), where adult participants were observed in controlled settings, sometimes compared against other treatments in the same therapeutic area. Researchers monitored objective outcomes, such as the rate at which the damage to the esophageal lining was confirmed in studies to assess the endoscopic healing rate. They also examined patient-reported outcomes describing perceived discomfort, like the frequency and severity of heartburn.

Findings describe patterns observed in the studies where patients reported measurements of the healing endpoint over observation periods typically lasting four to eight weeks. The core healing trials focus on short-term results, and follow-up durations were limited in these initial trials. Research does not routinely capture data on outcomes extending over many years after the short-term course is completed.


Studies for Symptomatic Reflux and Ulcer Management

Research has explored the use of Domol in two other important areas: exploring outcomes in symptomatic reflux without visible damage and examining duodenal ulcer studies.

For patients with symptomatic non-erosive reflux disease (NERD)conditions where symptoms may vary in intensityshort-term RCTs were evaluated in adult and adolescent populations. These studies examined changes in outcomes related to physical discomfort. Studies report how symptoms evolved in the observed populations, though findings were mixed regarding the predictability of a full symptomatic response in this specific group of patients.

Domol was observed in clinical studies as a component of specific triple-therapy regimens (alongside antibiotics) for H. pylori eradication. These studies research examined whether the regimen was associated with specific patterns following ulcer therapy.

Key Studies & References Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) (ClinicalTrials.gov)

Frequently Asked Questions (FAQ)

Common questions about Domol (FAQ)


Q: Can Domol make you feel sleepy or tired?

A: According to official product information, somnolence (drowsiness or sleepiness) is listed as an uncommon adverse reaction, meaning it is reported in a small percentage of patients. Additionally, common side effects can include asthenia (a feeling of physical weakness or lack of energy) and fatigue. Patients are generally advised to be aware of how they react to the medicine before engaging in activities that require full mental alertness.


Q: What happens if I take Domol and alcohol together?

A: Regulatory safety advice often suggests caution or avoidance of alcohol while taking this medication. Alcohol consumption may sometimes increase stomach acid levels, which could potentially reduce the medicine’s efficiency. Any specific instructions or warnings regarding alcohol use should be followed.


Q: How long does the effect of Domol usually last?

A: Studies indicate that the therapeutic effect of a single dose of Domol is sustained for a significant period. Although the medicine itself has a short elimination half-life in the bloodstream, its key action is irreversible: it blocks the acid pumps, and the body must create new ones for full acid secretion to resume. This sustained block is why it is often effective as a once-daily treatment.


Q: Is Domol a type of narcotic painkiller?

A: No, Domol is not classified as a narcotic or opioid painkiller. It belongs to the Proton Pump Inhibitor (PPI) class of drugs, and its primary purpose is to suppress the production of stomach acid. It is an anti-secretory medicine used to treat acid-related disorders.


Q: What is the difference between Domol and over-the-counter pain relievers?

A: Domol, as a Proton Pump Inhibitor, works specifically to reduce the amount of acid the stomach produces. This mechanism is entirely different from over-the-counter pain relievers, such as NSAIDs, which generally work by blocking chemicals that cause pain and inflammation. Domol and typical pain relievers belong to distinct pharmacological classes.


Q: What should I avoid while taking Domol?

A: Official labeling states that you must avoid medicines that are formally contraindicated (prohibited), such as rilpivirine-containing products. Caution is also specifically advised with certain drugs, including warfarin and methotrexate, which may require careful monitoring or temporary adjustment to your regimen. The full medication list should be reviewed with the prescribing healthcare provider.


Q: Is it normal to feel a bit dizzy when starting Domol?

A: Dizziness is documented in the official safety profile as a common side effect in some populations, and other nervous system reactions, like nervousness or somnolence (drowsiness), are also possible. Patients experiencing severe or persistent side effects like dizziness should consult their healthcare provider.


Q: Are there any foods or supplements that interact with Domol?

A: Regulatory information indicates that the medicine’s acid-reducing effect can alter the absorption of other substances whose uptake is dependent on stomach pH. This includes some medicines and supplements like Iron salts or the potential for Vitamin B12 deficiency with very long-term use. It is important that all major interactions are discussed with a healthcare professional.


Q: How long does Domol stay in your system?

A: The medicine is rapidly absorbed after taking it, and its active components are quickly metabolized by the liver. The majority of the metabolic breakdown products are excreted primarily through the kidneys. Although the drug is cleared relatively quickly from the blood, its therapeutic effect persists because it has irreversibly blocked the acid-producing pumps in the stomach lining.


Q: Why is Domol sometimes given with food and sometimes without?

A: For most of the conditions it treats, official guidelines allow Domol to be taken with or without food. However, specific regimens, such as those used for treating duodenal ulcers, may instruct the patient to take the dose with or immediately after a meal. This timing variation is often related to the specific condition being treated.


Q: Why is my pharmacy asking me about other medicines before dispensing Domol?

A: Your pharmacy performs a crucial safety check because Domol has known interactions with many other drugs. The medication can alter the effectiveness or safety of others, for example, by affecting drug absorption or increasing the risk of cardiac events when combined with certain high-risk medicines. This process helps ensure that your full regimen is reviewed for safety.


Q: Is it possible to become dependent on Domol?

A: Domol is not classified as a substance that causes physical dependence. However, regulatory information notes that withdrawal after prolonged use may result in rebound acid hypersecretion. This is a temporary increase in acid production, and it is a known physiological effect of stopping this class of medication.


Q: Does taking Domol interfere with lab tests?

A: Yes, official labeling notes that the medicine can interfere with certain lab tests, specifically investigations for neuroendocrine tumors. This effect is due to an increase in the level of the substance Chromogranin A ( CgA) in the blood. A healthcare provider will determine if treatment needs to be stopped for a period before CgA measurements.


Q: Are there any non-pain conditions that Domol is sometimes used for?

A: Yes. Approved non-pain conditions include being used as a component of specific combination therapies to eradicate the extitHelicobacter pylori bacterium. It is also approved for treating rare, severe acid-related disorders like Zollinger-Ellison Syndrome.


Q: Is Domol used in combination with other pain medicines?

A: The product is officially indicated for use in combination with specific antibiotics (often called 'triple therapy') to eradicate the extitH. pylori infection. It is not currently indicated for general use in combination with other pain medicines, though its use is aimed at reducing acid-related discomfort.


Q: Is there a maximum amount of time I should take Domol?

A: While short-term treatment courses typically last 4 to 8 weeks, regulatory warnings advise that prolonged daily use, such as use lasting longer than three years, is associated with certain risks. These risks include the potential for Vitamin B12 deficiency and an increased risk of bone fracture.


Q: Can Domol be crushed or chewed?

A: No. The delayed-release tablets must be swallowed whole and should not be crushed, split, or chewed. This requirement is necessary because the active ingredient is protected by a special enteric coating that must remain intact. If the coating is broken, the medicine may not work as intended.


Q: Can people with heart conditions use Domol?

A: Caution is advised. The medicine is formally contraindicated (prohibited) if a patient is taking other medications that are known to prolong the QTc interval in the heart, as this creates a higher risk of serious cardiac events. Any pre-existing cardiac issues should be fully disclosed to the prescriber.


Q: How does the mechanism of Domol differ from NSAIDs?

A: The mechanism of Domol (a PPI) is to inhibit the Proton Pump to stop acid secretion in the stomach. NSAIDs work by blocking enzymes that lead to pain and inflammation (cyclooxygenase-1 and -2). They have distinct actions and are used for different therapeutic goals.


Q: What happens if I take Domol too close to my other medications?

A: The acid-suppressing effect of Domol can change the pH environment of the stomach, which is the primary concern with timing. This change may result in the reduced absorption of some drugs or the increased absorption of others. Specific spacing instructions may need to be followed if provided by the healthcare provider.


Q: Does Domol interact with commonly used herbal remedies?

A: The official label warns against combining the medicine with strong CYP3A4 inhibitors. Since some popular herbal supplements can interact with this enzyme system, patients should consult with a healthcare provider before using any herbal or dietary supplement while on this medication.


Q: Can Domol affect mood or cause anxiety?

A: The official safety profile lists nervousness as an uncommon adverse reaction, meaning it is reported in less than one percent of patients. While other psychological effects are not commonly documented, any persistent change in mood or anxiety level may warrant consulting a healthcare professional.

How should Domol be stored and disposed of?

To maintain the stability and effectiveness of Domol, store it in its original container, tightly closed. The medicine should be kept in a cool, dry place, protected from direct sunlight, heat, and excessive moisture. It is generally recommended to store it at or below 30°C (86°F), unless otherwise specified on the packaging. Always keep Domol out of the sight and reach of children and pets to prevent accidental ingestion.


Storage Conditions Disposal Guidelines
Store in a cool, dry place. Do not flush unused medication down the toilet or pour into a drain, unless specifically instructed to do so.
Keep below 30°C (86°F). The best method for disposal is a drug take-back program or a community collection event.
Protect from light and moisture. If a take-back option is unavailable, mix the medicine (without crushing the tablet/capsule) with an undesirable substance like kitty litter or used coffee grounds.
Keep in its original, tightly closed container. Place the mixture in a sealed plastic bag or container, then discard in the household trash.
Keep out of reach of children and pets. Scratch out all personal information on the prescription label before discarding the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Domol found in:

A-Z Index: